Bicycle Therapeutics plc (BCYC) Net margin 2017–2025
Bicycle Therapeutics plc (BCYC) net profit margin by fiscal year — reported net income divided by reported revenue.
-301.7%FY2025 · since FY2017: -789.3% → -301.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -301.7% | +177.5 pp |
| FY2024 | -479.2% | +190.5 pp |
| FY2023 | -669.7% | +109.6 pp |
| FY2022 | -779.3% | -208.1 pp |
| FY2021 | -571.2% | -80.3 pp |
| FY2020 | -491.0% | -269.2 pp |
| FY2019 | -221.8% | +84.4 pp |
| FY2018 | -306.1% | +483.1 pp |
| FY2017 | -789.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Gross profitBCYC Gross marginBCYC Operating incomeBCYC Operating marginBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →